Monthly Archives: September 2011

Is non-adherence understated? New study says yes

The current edition of Drug Topics reports on a study (published last month in Annals of Pharmacotherapy) which suggests initial prescription abandonment should be considered non-adherence (I agree!).  And then determines that, based on that principle, adherence rates were overstated … Continue reading

Posted in Uncategorized | 1 Comment

New Page for External Adherence Resource Links

I’ve added a new page for web resources on adherence that I find interesting and re-visitable. Single purpose links will continue to show up in posts instead! If you have suggestions on other high-quality links, please post in comments or … Continue reading

Posted in Uncategorized | Comments Off

Anticounterfeiting meets Occam’s Razor

Nice to see some simple approaches designed to combat counterfeit drugs in developing markets.  Forget the complex RFID, symbology driven, high infrastructure cost under discussion for the US market. Instead, how about scratchoff blisters plus cell phone authentication!  A great … Continue reading

Posted in Uncategorized | Comments Off

DIABETES: Optimizing Drug Design – from the NIH

Nice to see respected parties such as the NIH advocating for optimizing diabetes drug design, to minimize side effects.  But even this great writeup leaves money on the table, by not then linking side effect profiles to the known poor … Continue reading

Posted in Uncategorized | Tagged , , , | Comments Off

Diabetes – redesigning injection adherence

Some interesting abstracts presented at this week’s European Association for the Study of Diabetes annual meeting in Lisbon show how advanced drug delivery can be applied to improve patient experience and adherence.  (I have no connection to the companies involved, … Continue reading

Posted in Uncategorized | Tagged , , | Comments Off